Methadone, which is used as maintenance medication for outpatient treatment of opioid dependence or as an analgesic drug, has been suggested by preclinical in vitro and mouse studies to induce cell death and sensitivity to chemo- or radiotherapy in leukemia, glioblastoma, and carcinoma cells. These data together with episodical public reports on long-term surviving cancer patients who use methadone led to a hype of methadone as an anti-cancer drug in social and public media. However, clinical evidence for a tumoricidal effect of methadone is missing and prospective clinical trials, except in colorectal cancer, are not envisaged because of the limited preclinical data available. The present article reviews the pharmacokinetics, potential molecular targets, as well as the evidence for a tumoricidal effect of methadone in view of the therapeutically achievable doses in the brain. Moreover, it provides original in vitro data showing that methadone at clinically relevant concentrations fails to impair clonogenicity or radioresistance of glioblastoma cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356722PMC
http://dx.doi.org/10.3390/biom10060917DOI Listing

Publication Analysis

Top Keywords

evidence tumoricidal
8
tumoricidal methadone
8
methadone
6
repurposing methadone
4
methadone glioblastoma
4
glioblastoma therapy
4
therapy methadone
4
methadone maintenance
4
maintenance medication
4
medication outpatient
4

Similar Publications

Trained immunity (TI) is functional memory displayed by innate immune cells (IICs). TI facilitates rapid, non-specific responses to pathogens upon secondary challenge. It is driven by immunological signaling and metabolic rewriting epigenetic alteration, triggered by recognition of certain stimuli.

View Article and Find Full Text PDF

Euphorbia helioscopia L. inhibits lung tumorigenesis through alleviating exhausted T cell induced by chronic inflammation.

J Ethnopharmacol

February 2025

School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, 330004, China; National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, 330006, China; Key Laboratory for Evaluation on Anti-Tumor Effect of Chinese Medicine by Strengthening Body Resistance to Eliminate Pathogenic Factors, Nanchang, 330006, China; Key Laboratory of Effective Material Basis of TCM, Jiangxi Province, Jiangxi University of Chinese Medicine, Nanchang, 330006, China. Electronic address:

Ethnopharmacological Relevance: Euphorbia helioscopia L. (ZQ) is a very effective traditional Chinese medicine for treating pneumonia and lung cancer. However, the effects and mechanisms by which ZQ prevents lung tumorigenesis in the presence of chronic inflammation remain unexplored.

View Article and Find Full Text PDF

Accumulating evidence demonstrates that the "Warburg effect" that glycolysis is enhanced even in the presence of oxygen existed in hematopoietic malignancies, contributing to extracellular acidosis. G-protein coupled receptor 68 (GPR68), as a proton sensing GPCR responding to extracellular acidosis, is expected to play a critical role in hematopoietic malignancies. In the present study, we found that GPR68 was overexpressed in acute myeloid leukemia (AML) cells, and GPR68 deficiency impaired AML cell survival in vitro and cell engraftment in vivo.

View Article and Find Full Text PDF
Article Synopsis
  • Therapeutic tumor vaccines offer a promising treatment for advanced prostate cancer, especially for patients who have had a relapse or cannot undergo surgery.
  • Researchers reviewed various types of vaccines, including dendritic cell and nucleic acid vaccines, to assess their safety and effectiveness.
  • Results indicate that these vaccines have favorable safety profiles and show strong clinical outcomes, but their development and implementation face significant challenges, highlighting the need for future research in combination therapies and understanding the immune system's role in cancer.
View Article and Find Full Text PDF
Article Synopsis
  • - Isoliquiritigen (ISL), a component of licorice, has been shown to significantly suppress breast tumor growth in immunocompetent mice by boosting the presence of CD8 T lymphocytes compared to immunocompromised mice.
  • - Treatment with ISL also leads to a notable decrease in PD-L1 levels in both tumor tissues and cultured breast cancer cells, with evidence linking this reduction to increased levels of miR-200c, which targets PD-L1.
  • - The study suggests that ISL enhances tumor suppression by interfering with specific signaling pathways (ERK and Src) and improves the effectiveness of paclitaxel, a common chemotherapy drug, by bolstering the body’s immune response against
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!